{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T04:12:13Z","timestamp":1744949533882,"version":"3.40.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.retram.2024.103478","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T11:40:33Z","timestamp":1731584433000},"page":"103478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["DNMT3A-related overgrowth syndrome presenting with immune thrombocytopenic purpura"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3886-3808","authenticated-orcid":false,"given":"Abdullah","family":"Sezer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7906-4801","authenticated-orcid":false,"given":"\u00d6znur Kaya","family":"G\u00fcne\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bur\u00e7ak","family":"Kurucu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.retram.2024.103478_bib0001","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/ng.1009","article-title":"Dnmt3a is essential for hematopoietic stem cell differentiation","volume":"44","author":"Challen","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.retram.2024.103478_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106390","article-title":"DNA methylation plays an important role in immune thrombocytopenia","volume":"83","author":"Liu","year":"2020","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"10.1016\/j.retram.2024.103478_bib0003","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1182\/blood-2011-07-369934","article-title":"DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications","volume":"119","author":"Hou","year":"2012","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.retram.2024.103478_bib0004","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1182\/blood-2011-03-343988","article-title":"Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia","volume":"118","author":"Shen","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.retram.2024.103478_bib0005","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nrc3895","article-title":"DNMT3A in haematological malignancies","volume":"15","author":"Yang","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.retram.2024.103478_bib0006","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ng.2917","article-title":"Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability","volume":"46","author":"Tatton-Brown","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.retram.2024.103478_bib0007","doi-asserted-by":"crossref","first-page":"46","DOI":"10.12688\/wellcomeopenres.14430.1","article-title":"The Tatton-Brown-Rahman syndrome: a clinical study of 55 individuals with de novo constitutive DNMT3A variants","volume":"3","author":"Tatton-Brown","year":"2018","journal-title":"Wellcome Open Res"},{"issue":"9","key":"10.1016\/j.retram.2024.103478_bib0008","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1136\/jmg-2024-110031","article-title":"Expanding the genetic and clinical spectrum of Tatton-Brown-Rahman syndrome in a series of 24 French patients","volume":"61","author":"Thomas","year":"2024","journal-title":"J Med Genet"},{"issue":"4","key":"10.1016\/j.retram.2024.103478_bib0009","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3324\/haematol.2021.278990","article-title":"Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome","volume":"107","author":"Tovy","year":"2022","journal-title":"Haematologica"},{"issue":"14","key":"10.1016\/j.retram.2024.103478_bib0010","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1182\/bloodadvances.2023009949","article-title":"Deciphering the genetic basis of immune thrombocytopenia: current evidence for genetic predisposition in adult ITP","volume":"7","author":"Georgi","year":"2023","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.retram.2024.103478_bib0011","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ped4.12309","article-title":"The role of epigenetics in childhood autoimmune diseases with hematological manifestations","volume":"6","author":"Gkoutsias","year":"2022","journal-title":"Pediatr Investig"},{"issue":"5","key":"10.1016\/j.retram.2024.103478_bib0012","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"26","key":"10.1016\/j.retram.2024.103478_bib0013","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1182\/blood-2009-01-129155","article-title":"Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity","volume":"113","author":"Cines","year":"2009","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.retram.2024.103478_bib0014","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s10875-020-00808-4","article-title":"Prevalence of immunological defects in a cohort of 97 Rubinstein-Taybi syndrome patients","volume":"40","author":"Saettini","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.retram.2024.103478_bib0015","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jpeds.2020.01.048","article-title":"The evaluation of hematologic screening and perioperative management in patients with noonan syndrome: a retrospective chart review","volume":"220","author":"Briggs","year":"2020","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.retram.2024.103478_bib0016","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/bjh.19461","article-title":"Kabuki syndrome complicated by severe immune thrombocytopenia and autoimmune thyroiditis: identification of a novel pathogenic mutation","volume":"205","author":"Qu","year":"2024","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.retram.2024.103478_bib0017","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.smim.2005.01.005","article-title":"DNA methylation and the expanding epigenetics of T cell lineage commitment","volume":"17","author":"Wilson","year":"2005","journal-title":"Semin Immunol"},{"issue":"4","key":"10.1016\/j.retram.2024.103478_bib0018","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1751-553X.2012.01404.x","article-title":"Role of DNA methyltransferase 3A mRNA expression in Egyptian patients with idiopathic thrombocytopenic purpura","volume":"34","author":"El-Shiekh","year":"2012","journal-title":"Int J Lab Hematol"},{"issue":"3","key":"10.1016\/j.retram.2024.103478_bib0019","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood.2021014052","article-title":"DNMT3A overgrowth syndrome is associated with the development of hematopoietic malignancies in children and young adults","volume":"139","author":"Ferris","year":"2022","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.retram.2024.103478_bib0020","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10875-008-9198-z","article-title":"Single nucleotide polymorphism in DNMT3B promoter and the risk for idiopathic thrombocytopenic purpura in Chinese population","volume":"28","author":"Chen","year":"2008","journal-title":"J Clin Immunol"},{"issue":"5","key":"10.1016\/j.retram.2024.103478_bib0021","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s10875-008-9223-2","article-title":"Decreased DNA methyltransferase 3A and 3B mRNA expression in peripheral blood mononuclear cells and increased plasma SAH concentration in adult patients with idiopathic thrombocytopenic purpura","volume":"28","author":"Tao","year":"2008","journal-title":"J Clin Immunol"},{"issue":"11","key":"10.1016\/j.retram.2024.103478_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113411","article-title":"Distinct disease mutations in DNMT3A result in a spectrum of behavioral, epigenetic, and transcriptional deficits","volume":"42","author":"Beard","year":"2023","journal-title":"Cell Rep"},{"issue":"11","key":"10.1016\/j.retram.2024.103478_bib0023","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1002\/ajmg.a.38485","article-title":"The spectrum of DNMT3A variants in Tatton-Brown-Rahman syndrome overlaps with that in hematologic malignancies","volume":"173","author":"Shen","year":"2017","journal-title":"Am J Med Genet A"},{"issue":"7","key":"10.1016\/j.retram.2024.103478_bib0024","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1101\/gr.243584.118","article-title":"Growth disrupting mutations in epigenetic regulatory molecules are associated with abnormalities of epigenetic aging","volume":"29","author":"Jeffries","year":"2019","journal-title":"Genome Res"},{"issue":"1","key":"10.1016\/j.retram.2024.103478_bib0025","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1158\/2159-8290.CD-21-0560","article-title":"Systematic profiling of DNMT3A variants reveals protein instability mediated by the DCAF8 E3 ubiquitin ligase adaptor","volume":"12","author":"Huang","year":"2022","journal-title":"Cancer Discov"},{"issue":"4","key":"10.1016\/j.retram.2024.103478_bib26","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/labmed\/lmw040","article-title":"Association of DNA methyltransferase 3B promotor polymorphism with childhood chronic immune thrombocytopenia","volume":"47","author":"Gouda","year":"2016","journal-title":"Lab Med"},{"issue":"1","key":"10.1016\/j.retram.2024.103478_bib27","article-title":"DNA methyltransferase 3B gene promoter and interleukin\u20101 receptor antagonist polymorphisms in childhood immune thrombocytopenia","volume":"2012","author":"Pesmatzoglou","year":"2012","journal-title":"J Immunol Res"},{"issue":"1","key":"10.1016\/j.retram.2024.103478_bib28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.gene.2012.09.024","article-title":"DNA methyltransferase 3B (DNMT3B\u2212 579 G> T) promotor polymorphism and the susceptibility to pediatric immune thrombocytopenic purpura in Egypt","volume":"511","author":"Khorshied","year":"2012","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.retram.2024.103478_bib29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4103\/ejh.ejh_2_18","article-title":"DNA methyltransferases 3A\u2212 448 G\/A and 3B\u2212 149C\/T single-nucleotide polymorphisms in primary immune thrombocytopenia","volume":"43","author":"Abd-Elkader","year":"2018","journal-title":"Egypt J Haematol"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318624000400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318624000400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T07:52:01Z","timestamp":1744876321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318624000400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2452318624000400"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2024.103478","relation":{},"ISSN":["2452-3186"],"issn-type":[{"type":"print","value":"2452-3186"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNMT3A-related overgrowth syndrome presenting with immune thrombocytopenic purpura","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2024.103478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103478"}}